Premarket trading on Monday showed a mixed tilt as investors rotated through a slate of earnings, drug-company news, and geopolitical-driven energy plays. Goldman Sachs shares fell more than 2% despite the bank reporting a first-quarter earnings and revenue beat, a result the market framed against a softer showing in fixed-income trading. Revolution Medicines surged more than 37% after phase 3 results for its pancreatic cancer therapy, while a batch of consumer, homebuilding and technology names moved on upgrades, downgrades and merger talk. These moves come as investors weigh the fundamental backdrop of higher energy prices, the pace of inflation and the resilience of corporate earnings.
According to CNBC, Goldman Sachs posted better-than-expected first-quarter earnings and revenue, highlighted by record equities trading and stronger investment banking revenues. Yet fixed income, currencies and commodities (FICC) trading fell short of the consensus, with FICC revenue coming in at $4.01 billion versus the roughly $4.92 billion anticipated by analysts polled by FactSet. The mismatch helped drive a negative initial reaction in the stock, underscoring how investors remain focused on the FICC cycle as a potential bottleneck even when overall results beat expectations.
In the biotechnology space, Revolution Medicines leapt more than 37% after its pancreatic cancer drug daraxonrasib showed positive phase 3 data. The company said the daily pill extended overall survival, achieving a median of 13.2 months compared with 6.7 months for patients treated with chemotherapy, marking a potential material improvement for a hard-to-treat disease. Investors will scrutinize the durability of the response and the potential for regulatory uptake, with the stock’s breakout reflecting a swing factor for oncology portfolios amid an active biotech cycle.
Within consumer retail, Williams-Sonoma rose more than 2% after Goldman Sachs upgraded the retailer to Buy, citing an attractive valuation and what the bank described as one of the strongest portfolios of brands in retail. The upgrade underscores a broader theme of consumer brands benefiting from a diversified mix of premium segments, even as macro momentum remains a point of focus for discretionary spending.
Not all consumer names advanced. Best Buy was downgraded to Sell by Goldman Sachs, which argued that the retailer could face headwinds from higher memory costs that may pressure laptop pricing and, by extension, margins. The note highlighted a potential post-quarter pullback in demand as a risk factor, illustrating how hardware cycles and cost pressures can blur the path to near-term earnings in consumer electronics.
In the homebuilders space, Toll Brothers and PulteGroup rose more than 1% after Evercore ISI upgraded both stocks to Outperform. The firm framed the call as a dip-buying opportunity, saying the bad news is already priced in and that these players could navigate macro headwinds more effectively than peers. The move signals a shift in sentiment around the housing cycle, even as mortgage rates and construction costs remain key variables for demand and margins.
Fastenal slid more than 4% after reporting first-quarter earnings that met the Street’s expectations. The distributor of industrial and construction supplies posted earnings of 30 cents per share on revenue of about $2.2 billion, in line with analysts’ consensus. The result underscores a discipline in industrials where modest top-line gains can be met with shares retreating on tempered expectations for the cycle ahead.
Key takeaways
- Goldman Sachs shares down >2% despite a Q1 beat; weakness in FICC trading masked stronger equities and advisory revenue (catalyst: mix of earnings and sector read). Result implication: investors remain attentive to the FICC cycle and how it shapes bank profit pools.
- Revolution Medicines jumps >37% on phase 3 readout for daraxonrasib; survival benefit reported (OS) of 13.2 months vs 6.7 months with chemotherapy (catalyst: clinical trial data). Implication: potential near-term upside in oncology-focused investors and-related approvals.
- Energy names rally as oil surpasses $103 per barrel on geopolitical risk tied to Strait of Hormuz; names like Targa Resources, APA, Phillips 66, Chevron and Exxon Mobil show gains (catalyst: macro risk premium). Implication: higher energy equities amid supply concerns, with potential broader market sensitivity to energy undercurrents.
- Leggett & Platt up 9% on acquisition news; Somnigroup International to buy the company in a $2.5 billion all-stock deal, expected to close by year-end 2026 (catalyst: M&A). Implication: a notable industrials M&A move that could influence risk appetite for related suppliers and bedding manufacturers.
- Palantir rebounds >2% after a steep retreat last week on AI disruption fears; stock faces a volatile period with the prior week’s activity noted as the worst since April 2025 (catalyst: sentiment shift around AI exposure). Implication: ongoing rotation in software names amid AI narrative and profitability concerns.
What drove the move
Several factors shaped the premarket landscape. On the earnings front, Goldman Sachs delivered a balanced picture: stronger revenue streams from equities trading and investment banking helped offset softer FICC performance. The market’s read, however, remained disciplined, focusing on the drag from fixed-income activities and how that dynamic could temper overall profitability in a higher-rate environment.
In biotechnology, Revolution Medicines delivered a clearer catalyst for investors: a meaningful survival advantage in a late-stage study of its pancreatic cancer treatment. The magnitude of the survival benefit—if sustained in broader studies—frames potential for regulatory reconsideration and potential commercial opportunity, even as investors await further data on long-term outcomes and safety.
Retail and consumer-facing names moved on a mix of valuation signals and earnings previews. Williams-Sonoma’s upgrade to Buy from Goldman Sachs suggested the stock could offer a better risk-reward at current levels, reflecting confidence in the brand portfolio and positioning. By contrast, Best Buy’s downgrade underscored ongoing concerns around hardware cost pressures and the potential for commodity-driven cost headwinds to compress margins in a near-term outlook.
In the housing space, Evercore ISI’s upgrade of Toll Brothers and PulteGroup to Outperform indicated a belief that the sector could hold up relatively well against macro headwinds, with the firm arguing that the risk-reward for these names had improved after recent declines. The call aligns with a broader narrative that selective homebuilders may outperform as demand trends remain uneven but resilient in certain markets.
Energy complex dynamics dominated a portion of the session as crude prices traded above the $100 threshold, supported by geopolitical risk. The resulting strength in energy-related equities—ranging from midstream players to refining majors—highlights how a geopolitically charged environment can lift groups with direct exposure to oil and gas supply disruptions.
The travel and transport group did not escape the breath of higher energy costs and demand concerns. Cruise lines faced pressure from rising input costs and caution around demand revival, with Carnival, Norwegian and Royal Caribbean all trading lower. Airlines followed a similar script, with United, Southwest and Delta retreating on concerns about jet fuel costs and demand trajectories. These moves illustrate ongoing sensitivity of travel-related equities to energy costs and macro demand signals.
Palantir’s modest rebound after a recent slump reflects a nuanced stance toward AI-driven software firms. The stock’s retreat last week was among the steepest in months, and today’s uptick signals a potential recalibration as investors weigh AI-driven growth against profitability and competitive risk in enterprise software.
Market reaction
The broader equity market narrative remains one of cautious optimism tempered by pockets of risk. Sector-specific drivers—earnings quality, commodity prices, and geopolitics—continue to determine stock-specific trajectories. While some names benefited from upgrades and positive trial data, others were weighed down by revenue mix, cost pressures or macro uncertainty. Investors are tightening focus on the durability of mid-cycle earnings and the sensitivity of equities to energy prices, rates and geopolitical risk—themes that have dominated trading across several quarters.
What analysts are saying
Analysts’ notes and revisions provided color on several key moves. Goldman Sachs upgraded Williams-Sonoma to Buy, pointing to the retailer’s brand strength and favorable valuation dynamics. In contrast, the bank downgraded Best Buy to Sell, citing potential margin pressures from higher memory costs and a pull-forward of PC demand that could reverse in the near term. The dichotomy illustrates how sector and stock-specific factors can diverge even when earnings are broadly constructive.
Evercore ISI issued an upbeat stance on Toll Brothers and PulteGroup, upgrading both to Outperform and highlighting valuation and resilience in the housing cycle. The call reflects a view that the pullback in homebuilders may have priced in risk and that these franchises could outperform peers under a variable macro backdrop.
On the data side, Fastenal’s first-quarter result met consensus, reinforcing the notion that industrial distributors can post steady outcomes even as macro volatility persists. Within biotechnology, Revolution Medicines’ phase 3 success has not yet triggered a full regulatory pathway discussion, but the stock’s move signals a strong investor emphasis on late-stage oncology opportunities when trial data support meaningful clinical benefits.
Palantir’s rebound and legacy AI concerns continue to shape sentiment around software names with large-scale data and analytics platforms. Investors appear to be weighing the potential for AI-led growth against the risk of execution challenges in a competitive environment.
Bigger picture
The thematic backdrop remains anchored in a balance between growth catalysts and cost pressures. Energy markets are a key driver of near-term equity performance, given the sensitivity of travel, industrials and consumer-facing sectors to input costs and energy prices. The manufacturing and housing cycles continue to offer selective opportunities as pricing power evolves and consumer demand shows pockets of resilience. Investors will also be watching how corporate earnings translate into guidance as central banks calibrate policy paths in a volatile macro landscape.
Closing
What to watch next: upcoming earnings reports and guidance from peers, additional updates on the health of the fixed-income trading environment at major banks, and any new developments in the geopolitical landscape that could influence energy prices. Market participants will also be tracking macro data releases and central bank communications for signals on rates and inflation as the quarter unfolds.
